1. Adams DH, Neuberger JM: Patterns of graft rejection following liver transplantation. J Hepatol 10: 113-119, 1990.

2. Adams DH, Neuberger JM: Treatment of acute rejection. Sem Liver Dis 12: 80-88, 1992.

3. Arnold JC, Portmann BC, O'Grady JG, et al: Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. Hepatology 16: 285-292, 1992.

4. Batts KP, Moore SB, Perkins JD, et al: Influence of positive lymphocyte crossmatch and HLA mismatch in vanishing bile duct syndrome in human liver allografts. Transplantation 45: 376-379, 1988.

5. Benner KG, Lee RG, Keeffe EB, et al: Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 103: 1307-1312, 1992.

6. Bird G, Friend P, Donaldson P, et al: Hyperacute rejection in liver transplantation: A case report. Transplant Proc 21: 3742-3744, 1989.

7. Brunt EM, Peters MG, Flye MW, Hanto DW: Day-5 protocol liver allograft biopsies document early rejection episodes and are predictive of recurrent rejection. Surgery 111: 511-517, 1992.

8. Burdick JF, Vogelsang GB, Smith WJ, et al: Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med 318: 689-691, 1988.

9. Busuttil RW, Goldstein LI, Danovitch GM, et al: Liver transplantation today. Ann Intern Med 104: 377-389, 1986.

10. Colina F, Mollejo M, Moreno E, et al: Effectiveness of histopathological diagnoses in dysfunction of hepatic transplantation. Review of 146 histopathological studies from 53 transplants. Arch Pathol Lab Med 115: 998-1005, 1991.

11. Collins RH Jr, Cooper B, Nikaein A, et al: Graft-versus-host disease in a liver transplant recipient. Ann Intern Med 116: 391-392, 1992.

12. Craig FE, Gulley ML, Banks PM: Posttransplantation lymphoproliferative disorders. Am J Clin Pathol 99: 265-276, 1993.

13. D'Alessandro AM, Kalayoglu M, Sollinger HW, et al: The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 51: 157-163, 1991.

14. Davies SE, Portmann BC, O'Grady JG, et al: Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 13: 150-157, 1991.

15. Demetris AJ: The pathology of liver transplantation. Prog Liv Dis 9: 687-709, 1990.

16. Demetris AJ, Belle SH, Hart J, et al: Intraobserver and interobserver variation in the histopathological assessment of liver allograft rejection. Hepatology 14: 751-755, 1991.

17. Demetris AJ, Jaffe R, Sheahan DG, et al: Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection. Am J Pathol 125: 161-172, 1986.

18. Demetris AJ, Jaffe R, Starzl TE: A review of adult and pediatric post-transplant liver pathology. Pathol Annu 22 (pt 2): 347-386, 1987.

19. Demetris AJ, Jaffe R, Tzakis A, et al: Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol 132: 489-502, 1988.

20. Demetris AJ, Lasky S, Van Thiel DH, et al: Pathology of hepatic transplantation. A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steriod regimen. Am J Pathol 118: 151-161, 1985.

21. Demetris AJ, Markus BH: Immunopathology of liver transplantation. CRC Crit Rev Immunol 9: 67-92, 1989.

22. Demetris AJ, Markus BH, Esquivel C, et al: Pathologic analysis of liver transplantation for primary biliary cirrhosis. Hepatology 8: 939-947, 1988.

23. Demetris AJ, Nakamura K, Yagihashi A, et al: A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology 16: 671-681, 1992.

24. Demetris AJ, Qian S, Sun H, Fung JJ: Liver allograft rejection: An overview of morphologic findings. Am J Surg Pathol 14 (suppl 1): 49-63, 1990.

25. Demetris AJ, Todo S, Van Thiel DH, et al: Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. Am J Pathol 137: 667-676, 1990.

26. Dietze O, Vogel W, Margreiter R, Mikuz G: Early recurrence of primary biliary cirrhosis after liver transplantation. Gastroenterology 98: 1106-1107, 1990.

27. Donaldson PT, Alexander GJM, O'Grady JG, et al: Evidence for an immune response to HLA class I antigens in the vanishing bile duct syndrome after liver transplantation. Lancet 1: 945-948, 1987.

28. Eggink HF, Hofstee N, Gips CH, et al: Histopathology of serial graft biopsies from liver transplant recipients. Am J Pathol 114: 18-31, 1984.

29. Esquivel CO, Jaffe R, Gordon RD, et al: Liver rejection and its differentiation from other causes of graft dysfunction. Sem Liver Dis 5: 369-374, 1985.

30. Fagan E, Yousef G, Brahm J, et al: Persistence of hepatitis A in fulminant hepatitis and after liver transplantation. J Med Virol 30: 131-136, 1990.

31. Fennell RH, Vierling JM: Electron microscopy of rejected human liver allografts. Hepatology 5: 1083-1087, 1985.

32. Ferrell LD, Wright TL, Roberts J, et al: Hepatitis C viral infection in liver transplant recipients. Hepatology 16: 865-876, 1992.

33. Freese DK, Snover DC, Sharp HL, et al: Chronic rejection after liver transplantation: A study of clinical, histopathological and immunological features. Hepatology 13: 882-891, 1991.

34. Goldstein NS, Hart J, Lewin KJ: Diffuse hepatocyte ballooning in liver biopsies from orthotopic liver transplant patients. Histopathology 18: 331-338, 1991.

35. Gonzalez EM, Gomez R, Garcia I, et al: Liver transplantation in malignant primary hepatic neoplasms. Am J Surg 163: 395-400, 1992.

36. Gorensek MJ, Carey WD, Vogt D, et al: A multivariate analysis of risk factors for cytomegalovirus infection in liver transplant recipients. Gastroenterology 98: 1326-1332, 1990.

37. Gouw ASH, Snover DC, Grond J, et al: Acute rejection in human liver grafts: A comparative histologic study of cases maintained on azathioprine and prednisone versus cyclosporine A and low-dose steroids. Hum Pathol 19: 1036-1042, 1988.

38. Grond J, Gouw ASH, Poppema S, et al: Chronic rejection in liver transplants: A histopathologic analysis of failed grafts and antecedent serial biopsies. Transplant Proc 18 (supple 4): 128-135, 1986.

39. Hanto DW, Snover DC, Noreen HJ, et al: Hyperacute rejection of a human orthotopic liver allograft in a presensitized recipient. Clin Transplant 1: 304-310, 1987.

40. Hart J, Busuttil RW, Lewin KJ: Disease recurrence following liver transplantation. Am J Surg Pathol 14 (suppl 1): 79-91, 1990.

41. Henley KS, Lucey MR, Appelman HD, et al: Biochemical and histopathological correlation in liver transplant: The first 180 days. Hepatology 16: 688-693, 1992.

42. Hertzler GL, Millikan WJ: The surgical pathologist's role in liver transplantation. Arch Pathol Lab Med 115: 273-282, 1991.

43. Hubscher SG: Histological findings in liver allograft rejection -- new insights into the pathogenesis of hepatocellular damage in liver allografts. Histopathology 18: 377-383, 1991.

44. Hübscher SG, Adams DH, Buckels JAC, et al: Massive hemorrhagic necrosis of the liver after liver transplantation. J Clin Pathol 42: 360-370, 1989.

45. Hubscher SG, Buckels JAC, Elias E, et al: Vanishing bile-duct syndrome following liver transplantation -- is it reversible? Transplantation 51: 1004-1010, 1991.

46. Hubscher SG, Clements D, Elias E, McMaster P: Biopsy findings in cases of rejection of liver allograft. J Clin Pathol 38: 1366-1373, 1985.

47. Kakizoe S, Yanaga K, Starzl TE, et al: Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: Considerations of preservation and early immunologic injury. Hepatology 11: 932-941, 1990.

48. Kassianides C, Nussenblatt R, Palestine AG, et al: Liver injury from cyclosporine A. Dig Dis Sci 35: 693-697, 1990.

49. Kemnitz J, Ringe B, Cohnert TR, et al: Bile duct injury as a part of diagnostic criteria for liver allograft rejection. Hum Pathol 20: 132-143, 1989.

50. Klintmalm GBG, Nery JR, Husberg BS, et al: Rejection in liver transplantation. Hepatology 10: 978-985, 1989.

51. Koneru B, Jaffe R, Esquivel CO, et al: Adenoviral infections in pediatric liver transplant recipients. JAMA 258: 489-492, 1987.

52. Kusne S, Schwartz M, Breinig MK, et al: Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis 163: 1001-1007, 1991.

53. Lake JR, Wright TL: Liver transplantation for patients with hepatitis B: What have we learned from our results? Hepatology 13: 796-799, 1991.

54. Lerut J, Gordon RD, Iwatsuki S, et al: Biliary tract complications in 393 human liver transplantations. Transplantation 43: 47-51, 1987.

55. Liu G, Butany J, Wanless IR, et al: The vascular pathology of human hepatic allografts. Hum Pathol 24: 182-188, 1993.

56. Lucey MR, Graham DM, Martin P, et al: Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation. Gut 33: 1390-1396, 1992.

57. Ludwig J: Classification and terminology of hepatic allograft rejection. Whither bound? Mayo Clin Proc 64: 676-679, 1989.

58. Ludwig J: Terminology of hepatic allograft rejection (glossary). Sem Liver Dis 12: 89-92, 1992.

59. Ludwig J, Batts KP, MacCarty RL: Ischemic cholangitis in hepatic allografts. Mayo Clin Proc 67: 519-526, 1992.

60. Ludwig J, Batts KP, Ploch M, et al: Endotheliitis in hepatic allografts. Mayo Clin Proc 64: 545-554, 1989.

61. Ludwig J, Gross JB Jr, Perkins JD, Moore SB: Persistent centrilobular necrosis in hepatic allografts. Hum Pathol 21: 656-661, 1990.

62. Ludwig J, Wiesner RH, Batts KP, et al: The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic transplantation. Hepatology 7: 476-483, 1987.

63. Luketic VA, Shiffman ML, McCall JB, et al: Primary hepatocellular carcinoma after orthotopic liver transplantation for chronic hepatitis B infection. Ann Intern Med 114: 212-213, 1991.

64. Markin RS, Hollins S, Wood RP, Shaw BW Jr: Main autopsy findings in liver transplant patients. Mod Pathol 2: 339-348, 1989.

65. Markin RS, Stratta RJ, Woods GL: Infection after liver transplantation. Am J Surg Pathol 14 (suppl 1): 64-78, 1990.

66. Markin RS, Wood RP, Shaw BW Jr, et al: Immunohistologic identification of Epstein-Barr virus-induced hepatitis reactivation after OKT-3 therapy following orthotopic liver transplant. Am J Gastroenterol 85: 1014-1018, 1990.

67. Martin P, Munoz SJ, Friedman LS: Liver transplantation for viral hepatitis: Current status. Am J Gastroenterol 87: 409-418, 1992.

68. McCaughan GW, Davies JS, Waugh JA, et al: A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: The use of monoclonal antibodies and double immunolabeling. Hepatology 12: 1305-1313, 1990.

69. Mor E, Solomon H, Gibbs JF, et al: Acute cellular rejection following liver transplantation: Clinical pathologic features and effect on outcome. Sem Liver Dis 12: 28-40, 1992.

70. Nalesnik MA, Jaffe R, Starzl TE, et al: The pathology of posttransplant lymphoproliferative disorders occurring inthe setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133: 173-192, 1988.

71. Neuberger J, Portmann B, Calne R, et al: Recurrence of autoimmune chronic active hepatitis following liver grafting. Transplantation 37: 363-365, 1984.

72. Neuberger J, Portmann B, Macdougall BRD, et al: Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med 306: 1-4, 1982.

74. Noack KB, Wiesner RH, Batts K, et al: Severe ductopenic rejection with features of vanishing bile duct syndrome: Clinical, biochemical, and histologic evidence for spontaneous resolution. Transplant Proc 23: 1448-1451, 1991.

75. O'Grady JG, Alexander GJM, Sutherland S, et al: Cytomegalovirus infection and donor/recipient HLA antigens: Interdependent co-factors in pathogenesis of vanishing bile duct syndrome after liver transplantation. Lancet 2: 302-305, 1988.

76. Oguma S, Belle S, Starzl TE, Demetris AJ: A histometric analysis of chronically rejected human liver allografts: Insights into the mechanisms of bile duct loss: Direct immunologic and ischemic factors. Hepatology 9: 204-209, 1989.

77. Paintaud G, Miguet JP: Diagnostic tools in liver allograft rejection. J Hepatol 12: 256-260, 1991.

78. Paya CV, Hermans PE, Washington JA II, et al: Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc 64: 555-564, 1989.

79. Paya CV, Holley KE, Wiesner RH, et al: Early diagnosis of cytomegalovirus hepatitis in liver transplant recipients: Role of immunostaining, DNA hybridization and culture of hepatic tissue. Hepatology 12: 119-126, 1990.

80. Perkins JD, Rakela J, Sterioff S, et al: Immunohistologic pattern of the portal T-lymphocyte infiltration in hepatic allograft rejection. Mayo Clin Proc 64: 565-569, 1989.

81. Phillips MJ, Cameron R, Flowers MA, et al: Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B. Am J Pathol 140: 1295-1308, 1992.

82. Pirsch JD, Kalayoglu M, Hafez GR, et al: Evidence that the vanishing bile duct syndrome is vanishing. Transplantation 49: 1015-1018, 1990.

83. Porter KA: The pathology of rejection in human liver allografts. Transplant Proc 20 (suppl 1): 483-485, 1988.

84. Portmann B, O'Grady J, Williams R: Disease recurrence following orthotopic liver transplantation. Transplant Proc 18 (suppl 4): 135-143, 1986.

85. Quiroga J, Colina I, Demetris AJ, et al: Cause and timing of first allograft failure in orthotopic liver transplantation: A study of 177 consecutive patients. Hepatology 14: 1054-1062, 1991.

86. Rakela J: Hepatitis C viral infection in liver transplant patients: How bad is it really? Gastroenterology 103: 338-339, 1992.

87. Randhawa PS, Markin RS, Starzl TE, Demetris AJ: Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipients. Clinical profile and recognition on routine allograft biopsy. Am J Surg Pathol 14: 538-547, 1990.

88. Ray RA, Lewin KJ, Colonna J, et al: The role of liver biopsy in evaluating acute allograft dysfunction following liver transplantation. A clinical histologic correlation of 34 liver transplants. Hum Pathol 19: 835-848, 1988.

89. Roberts JP, Ascher NL, Lake J, et al: Graft vs. host disease after liver transplantation in humans: A report of four cases. Hepatology 14: 274-281, 1991.

90. Russo PA, Yunis EJ: Subcapsular hepatic necrosis in orthotopic liver allografts. Hepatology 6: 708-713, 1986.

91. Sanchez-Urdazpal L, Gores GJ, Ward EM, et al: Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation. Hepatology 17: 605-609, 1993.

92. Sankary HN, Foster P, Hart M, et al: An analysis of the determinants of hepatic allograft rejection using stepwise logistic regression. Transplantation 47: 74-77, 1989.

93. Shah G, Demetris AJ, Gavaler JS, et al: Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology 103: 323-329, 1992.

94. Snover DC: Problems in the interpretation of liver biopsies after liver transplantation. Am J Surg Pathol 13 (suppl 1): 31-38, 1989.

95. Snover DC, Freese DK, Sharp HL, et al: Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol 11: 1-10, 1987.

96. Snover DC, Sibley RK, Freese DK, et al: Orthotopic liver transplantation: A pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology 4: 1212-1222, 1984.

97. Starzl TE, Demetris AJ, Todo S, et al: Evidence for hyperacute rejection of human liver grafts: The case of the canary kidney. Clin Transplant 3: 37-45, 1989.

98. Starzl TE, Demetris AJ, Van Thiel D: Liver transplantation (part 1 and 2). N Engl J Med 321: 1014-1022, 1092-1099, 1989.

99. Sterneck M, Wiesner R, Ascher N, et al: Azathioprine hepatotoxicity after liver transplantation. Hepatology 14: 806-810, 1991.

100. Stratta RJ, Shaeffer MS, Markin RS, et al: Cytomegalovirus infection and disease after liver transplantation. An overview. Dig Dis Sci 37: 673-688, 1992.

101. Thung SN, Gerber MA: Histologic features of liver allograft rejection: Do you see what I see? Hepatology 14: 949-951, 1991.

102. Tillery W, Demetris J, Watkins D, et al: Pathologic recognition of preservation injury in hepatic allograft with six months follow-up. Transplant Proc 21: 1330-1331, 1989.

103. Todo S, Demetris AJ, Makowka L, et al: Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 47: 903-905, 1989.

104. Todo S, Demetris AJ, Van Thiel D, et al: Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 13: 619-626, 1991.

105. van Hoek B, Wiesner RH, Krom RAF, et al: Severe ductopenic rejection following liver transplantation: Incidence, time of onset, risk factors, treatment, and outcome. Sem Liver Dis 12: 41-50, 1992.

106. Vierling JM: Immunologic mechanisms of hepatic allograft rejection. Sem Liver Dis 12: 16-27, 1992.

107. Vierling JM, Fennell RH Jr: Histopathology of early and late human hepatic allograft rejection: Evidence of progressive destruction of interlobular bile ducts. Hepatology 5: 1076-1082, 1985.

108. White RM, Zajko AB, Demetris AJ, et al: Liver transplant rejection: Angiographic findings in 35 patients. AJR 148: 1095-1098, 1987.

109. Whitington PF, Balistreri WF: Liver transplantation in pediatrics: Indications, contraindications, and pretransplant management. J Pediatr 118: 169-177, 1991.

110. Wiesner RH, Ludwig J, Krom RAF, et al: Hepatic allograft rejection: New development in terminology, diagnosis, prevention, and treatment. Mayo Clin Proc 68: 69-79, 1993.

111. Wiesner RH, Ludwig J, van Hoek B, Krom RAF: Current concepts in cell-mediated hepatic allograft rejection leading to ductopenai and liver failure. Hepatology 14: 721-729, 1991.

112. Wight DGD: Differential diagnosis of cholestasis in liver allografts. Transplant Proc 18: 152-156, 1986.

113. Williams JW, Foster PF, Sankary HN: Role of liver allograft biopsy in patient management. Sem Liver Dis 12: 60-72, 1992.

114. Williams JW, Peters TG, Vera SR, et al: Biopsy-directed immunosuppression following hepatic transplantation in man. Transplantation 39: 589-596, 1985.

115. Williams JW, Vera S, Peters TG, et al: Cholestatic jaundice after hepatic transplantation. A nonimmunologically mediated event. Am J Surg 151: 65-69, 1986.

116. Wisecarver JL, Earl RA, Haven MC, et al: Histologic changes in liver allograft biopsies associated with elevated whole blood and tisue cyclosporine concentrations. Mod Pathol 5: 611-616, 1992.

117. Wood RP, Rikkers LF, Shaw BW Jr, Williams L: A review of liver transplantation for gastroenterologists. Am J Gastro 82: 593-606, 1987.

118. Wright TL: Cytomegalovirus infection and vanishing bile duct syndrome: Culprit or innocent bystander? Hepatology 16: 494-496, 1992.

119. Wright TL, Donegan E, Hsu HH, et al: Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 103: 317-322, 1992.

120. Bernuau D, Gisselbrecht C, Devergie A, et al: Histological and ultrastructural appearance of the liver during graft-versus-host disease complicating bone marrow transplantation. Transplantation 29: 236-244, 1980.

121. Beschorner WE, Pino J, Boitnott JK, et al: Pathology of the liver with bone marrow transplantation. Effects of busulfan, carmustine, acute graft-versus-host disease, and cytomegalovirus infection. Am J Pathol 99: 369-386, 1980.

122. Ferrara JLM, Deeg HJ: Graft-versus-host disease. N Engl J Med 324: 667-674, 1991.

123. Gale RP: Graft-versus-host disease. Immunol Rev 88: 193-214, 1985.

124. Geubel AP, Cnudde A, Ferrant A, et al: Diffuse biliary tract involvement mimicking primary sclerosing cholangitis after bone marrow transplantation. J Hepatol 10: 23-28, 1990.

125. Knapp AB, Crawford JM, Rappeport JM, Gollan JL: Cirrhosis as a consequence of graft-versus-host disease. Gastroenterology 92: 513-519, 1987.

126. McDonald GB, Hinds MS, Fisher LD, et al: Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann Intern Med 118: 255-267, 1993.

127. McDonald GB, Sharma P, Matthews DE, et al: Venocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors. Hepatology 4: 116-112, 1984.

128. McDonald GB, Shulman HW, Sullivan KM, Spencer GD: Intestinal and hepatic complications of human bone marrow transplantation. Part I. Gastroenterology 90: 460-477, 1986.

129. McDonald GB, Shulman HW, Sullivan KM, Spencer GD: Intestinal and hepatic complications of human bone marrow transplantation. Part II. Gastroenterology 90: 770-784, 1986.

130. Shulman HM, McDonald GB: Liver disease after marrow transplantation. In Sale GE, Shulman HM (eds): The Pathology of Bone Marrow Transplantation. New York, Masson Publishing, 1984.

131. Shulman HM, McDonald GB, Matthews D, et al: An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 79: 1178-1191, 1980.

132. Shulman HM, Sharma P, Amos D, et al: A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation. Hepatology 8: 463-470, 1988.

133. Sloane JP, Farthing MJG, Powles RL: Histopathological changes in the liver after allogeneic bone marrow transplantation. J Clin Pathol 33: 344-350, 1980.

134. Snover DC: Biopsy interpretation in bone marrow transplantation. Pathol Annu 24 (pt 2): 63-101, 1989.

135. Snover DC, Weisdorf S, Bloomer J, et al: Nodular regenerative hyperplasia of the liver following bone marrow transplantation. Hepatology 9: 443-448, 1989.

136. Snover DC, Weisdorf SA, Ramsay NK, et al: Hepatic graft versus host disease: A study of the predictive value of liver biopsy in diagnosis. Hepatology 4: 123-130, 1984.

137. Stechschulte DJ Jr, Fishback JL, Emami A, Bhatia P: Secondary biliary cirrhosis as a consequence of graft-versus-host disease. Gastroenterology 98: 223-225, 1990.